Morning Movers 06/22: (HNR) (NPSP) Higher; (ARNA) (R) (RGEN) (EGLE) (PLX) Lower
Get Alerts HNR Hot Sheet
Join SI Premium – FREE
Harvest Natural Resources, Inc. (NYSE: HNR) 69.1% HIGHER; wholly-owned subsidiary, HNR Energia B.V., has signed a definitive Share Purchase Agreement (SPA) with PT Pertamina (Persero), the national oil company of Indonesia (the Buyer), to sell all of the Company's interests in Venezuela for $725.0 million in an all-cash transaction. Net proceeds from the sale are estimated to be approximately $525.0 million after deductions for transaction related costs and taxes.
Arena Pharma (Nasdaq: ARNA) 11.5% LOWER; three words: "massive bear raid." Click here for more details.
Ryder (NYSE: R) 11.3% LOWER; lowers its Q2 EPS guidance from $1.07-$1.12 previously to $0.90-$0.95, which compares to the Street estimate of $1.10. The company's FY12 EPS outlook moves from $4.02-$4.12 to $3.65-$3.85, which compares to the Street estimate of $4.09. The company cited "reduced commercial rental demand and actions taken to reduce used vehicle inventories.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) 10.1% HIGHER; Takeda Pharmaceutical Company Limited and NPS jointly announced today that the Committee for Medicinal Products for Human Use (of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product teduglutide (tradename in Europe: Revestive®) as a once-daily treatment for adult patients with short bowel syndrome.
Repligen Corporation (Nasdaq: RGEN) 9.8% LOWER; has received a Complete Response Letter (CRL) from the U.S. Food & Drug Administration (FDA) regarding the Company’s New Drug Application (NDA) for RG1068
Eagle Bulk Shipping (Nasdaq: EGLE) 9.1% LOWER; traders taking some profits this morning as the stock was up more than 31 percent. The company announced a new $20 million credit pact yesterday.
Protalix BioTherapeutics (AMEX: PLX) 9% LOWER; shares are lower following news taliglucerase alfa did not get marketing approval from the EMA CHMP.
Arena Pharma (Nasdaq: ARNA) 11.5% LOWER; three words: "massive bear raid." Click here for more details.
Ryder (NYSE: R) 11.3% LOWER; lowers its Q2 EPS guidance from $1.07-$1.12 previously to $0.90-$0.95, which compares to the Street estimate of $1.10. The company's FY12 EPS outlook moves from $4.02-$4.12 to $3.65-$3.85, which compares to the Street estimate of $4.09. The company cited "reduced commercial rental demand and actions taken to reduce used vehicle inventories.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) 10.1% HIGHER; Takeda Pharmaceutical Company Limited and NPS jointly announced today that the Committee for Medicinal Products for Human Use (of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product teduglutide (tradename in Europe: Revestive®) as a once-daily treatment for adult patients with short bowel syndrome.
Repligen Corporation (Nasdaq: RGEN) 9.8% LOWER; has received a Complete Response Letter (CRL) from the U.S. Food & Drug Administration (FDA) regarding the Company’s New Drug Application (NDA) for RG1068
Eagle Bulk Shipping (Nasdaq: EGLE) 9.1% LOWER; traders taking some profits this morning as the stock was up more than 31 percent. The company announced a new $20 million credit pact yesterday.
Protalix BioTherapeutics (AMEX: PLX) 9% LOWER; shares are lower following news taliglucerase alfa did not get marketing approval from the EMA CHMP.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Midday movers: FedEx soars; Nike, Lululemon and Tesla fall
- Reddit (RDDT) tagged as a new short idea at Hedgeye, stock tumbles
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!